Exome Asset Management LLC
Filing Date
Global Rank
#5,047
/ 8,700
▲ 1421
Top Industry
Biotechnology
68.3%
Period ended 2 months ago
Filed Aug 14, 2026 · 30d
11 quarters · since Dec 2023
Portfolio Concentration
52 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
6.2%
−2.3 pts
Top 5
26.8%
−2.2 pts
Top 10
44.5%
−3.1 pts
HHI
300
Diversified−46
Portfolio Trend
11 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $162,132,304 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | +26,182 | 114,692 | $3,422,409 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ADAG | Adagene Inc. | −248,552 | 488,293 | $2,050,830 | |
| RLAY | Relay Therapeutics, Inc. | −230,771 | 47,531 | $889,305 | |
| VSTM | Verastem, Inc. | −207,659 | 429,041 | $1,638,936 | |
| ELVN | Enliven Therapeutics, Inc. | −119,888 | 100,203 | $5,085,302 | |
| ALMS | Alumis Inc. | −74,758 | 204,418 | $5,752,322 | |
| COGT | Cogent Biosciences, Inc. | −68,010 | 210,523 | $8,147,240 | |
| CTMX | CytomX Therapeutics, Inc. | −61,401 | 460,067 | $1,725,251 | |
| AGIO | Agios Pharmaceuticals, Inc. | −54,560 | 70,500 | $2,616,255 | |
| TXG | 10x Genomics, Inc. | −51,565 | 102,629 | $3,934,795 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | −49,222 | 184,914 | $1,734,493 | |
| BBIO | BridgeBio Pharma, Inc. | −49,133 | 18,359 | $1,367,378 | |
| MLTX | MoonLake Immunotherapeutics | −48,883 | 166,493 | $3,241,618 | |
| CYTK | Cytokinetics Inc | −43,662 | 60,056 | $5,116,170 | |
| GLUE | Monte Rosa Therapeutics, Inc. | −42,369 | 137,115 | $3,318,183 | |
| ZBIO | Zenas BioPharma, Inc. | −28,287 | 52,443 | $1,331,003 | |
| CBIO | Crescent Biopharma, Inc. | −25,422 | 127,769 | $2,299,842 | |
| ABUS | Arbutus Biopharma Corp | −25,318 | 50,166 | $240,796 | |
| ALKS | Alkermes plc. | −22,767 | 61,336 | $3,214,006 | |
| IONS | Ionis Pharmaceuticals Inc | −21,887 | 88,177 | $6,991,554 | |
| PRAX | Praxis Precision Medicines, Inc. | −18,264 | 27,205 | $9,107,961 | |
| VERA | Vera Therapeutics, Inc. | −17,715 | 97,276 | $4,174,113 | |
| GH | Guardant Health, Inc. | −15,236 | 67,500 | $10,127,025 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | −13,507 | 32,214 | $2,625,763 | |
| INSM | INSMED Inc | −12,778 | 13,873 | $1,479,139 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | −8,372 | 32,209 | $3,576,165 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
15 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TGTX | Tg Therapeutics, Inc. | 164,915 | $9,060,430 | |
| ABVX | Abivax S.A. | 46,878 | $6,246,962 | |
| QURE | uniQure N.V. | 81,056 | $3,733,439 | |
| AZN | Astrazeneca PLC | 12,045 | $2,283,972 | |
| VKTX | Viking Therapeutics, Inc. | 47,861 | $1,867,057 | |
| OCUL | Ocular Therapeutix, Inc | 181,588 | $1,783,194 | |
| EQ | Equillium, Inc. | 552,956 | $1,769,459 | |
| ASND | Ascendis Pharma A/S | 6,573 | $1,753,150 | |
| NKTR | Nektar Therapeutics | 22,417 | $1,564,930 | |
| CLPT | ClearPoint Neuro, Inc. | 83,636 | $1,492,066 | |
| CAI | Caris Life Sciences, Inc. | 78,180 | $1,393,167 | |
| GERN | Geron Corp | 624,046 | $798,778 | |
| DRUG | Bright Minds Biosciences Inc. | 10,110 | $709,722 | |
| CMPX | Compass Therapeutics, Inc. | 276,165 | $604,801 | |
| REPL | Replimune Group, Inc. | 40,361 | $446,796 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| BWX | State Street SPDR Bloomberg International Treasury Bond ETF | 60,000 | $7,663,800 | |
| ELV | Elevance Health, Inc. | 14,677 | $4,296,691 | |
| AVTX | Avalo Therapeutics, Inc. | 159,341 | $2,378,961 | |
| NXTC | NextCure, Inc. | 115,500 | $1,233,540 | |
| FDMT | 4D Molecular Therapeutics, Inc. | 130,564 | $1,215,550 | |
| PALI | Palisade Bio, Inc. | 600,000 | $1,050,000 | |
| LPCN | Lipocine Inc. | 60,861 | $486,279 | |
| — | 85,517 | $0 | ||
| — | 61,673 | $0 | ||
| No positions match the current search. | ||||
52 tracked positions ·
$162,132,304 total
· filing declares
52 positions · $162,102,170
· as of Jun 30, 2026
Showing 1–50
of 52 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| GH |
Guardant Health, Inc.
Healthcare
|
Reduced | 67,500 | $10,127,025 | 6.25% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Reduced | 27,205 | $9,107,961 | 5.62% | |
| TGTX |
Tg Therapeutics, Inc.
Healthcare
|
NEW | 164,915 | $9,060,430 | 5.59% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 210,523 | $8,147,240 | 5.03% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Reduced | 88,177 | $6,991,554 | 4.31% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 5,492 | $6,587,270 | 4.06% | |
| ABVX |
Abivax S.A.
Healthcare
|
NEW | 46,878 | $6,246,962 | 3.85% | |
| ALMS |
Alumis Inc.
Healthcare
|
Reduced | 204,418 | $5,752,322 | 3.55% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 60,056 | $5,116,170 | 3.16% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Reduced | 100,203 | $5,085,302 | 3.14% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 97,276 | $4,174,113 | 2.57% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Reduced | 9,612 | $3,995,035 | 2.46% | |
| TXG |
10x Genomics, Inc.
Healthcare
|
Reduced | 102,629 | $3,934,795 | 2.43% | |
| NTRA |
Natera, Inc.
Healthcare
|
Reduced | 13,800 | $3,746,010 | 2.31% | |
| QURE |
uniQure N.V.
Healthcare
|
NEW | 81,056 | $3,733,439 | 2.30% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Reduced | 32,209 | $3,576,165 | 2.21% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Added | 114,692 | $3,422,409 | 2.11% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Reduced | 137,115 | $3,318,183 | 2.05% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Reduced | 166,493 | $3,241,618 | 2.00% | |
| ALKS |
Alkermes plc.
Healthcare
|
Reduced | 61,336 | $3,214,006 | 1.98% | |
| LQDA |
Liquidia Corp
Healthcare
|
Reduced | 39,224 | $3,127,329 | 1.93% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Reduced | 5,410 | $2,931,300 | 1.81% | |
| GKOS |
GLAUKOS Corp
Healthcare
|
Reduced | 19,862 | $2,775,913 | 1.71% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Reduced | 32,214 | $2,625,763 | 1.62% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Reduced | 70,500 | $2,616,255 | 1.61% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
Reduced | 127,769 | $2,299,842 | 1.42% | |
| AZN |
Astrazeneca PLC
Healthcare
|
NEW | 12,045 | $2,283,972 | 1.41% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Held | 48,347 | $2,063,449 | 1.27% | |
| ADAG |
Adagene Inc.
Healthcare
|
Reduced | 488,293 | $2,050,830 | 1.26% | |
| PEN |
Penumbra Inc
Healthcare
|
Held | 6,300 | $1,989,225 | 1.23% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 4,908 | $1,951,813 | 1.20% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
NEW | 47,861 | $1,867,057 | 1.15% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
NEW | 181,588 | $1,783,194 | 1.10% | |
| EQ |
Equillium, Inc.
Healthcare
|
NEW | 552,956 | $1,769,459 | 1.09% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
NEW | 6,573 | $1,753,150 | 1.08% | |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
Healthcare
|
Reduced | 184,914 | $1,734,493 | 1.07% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Reduced | 460,067 | $1,725,251 | 1.06% | |
| VSTM |
Verastem, Inc.
Healthcare
|
Reduced | 429,041 | $1,638,936 | 1.01% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
NEW | 22,417 | $1,564,930 | 0.97% | |
| CLPT |
ClearPoint Neuro, Inc.
Healthcare
|
NEW | 83,636 | $1,492,066 | 0.92% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 13,873 | $1,479,139 | 0.91% | |
| CAI |
Caris Life Sciences, Inc.
Healthcare
|
NEW | 78,180 | $1,393,167 | 0.86% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 18,359 | $1,367,378 | 0.84% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
Reduced | 52,443 | $1,331,003 | 0.82% | |
| NBP |
NovaBridge Biosciences
Healthcare
|
Held | 576,960 | $1,125,072 | 0.69% | |
| ESTA |
Establishment Labs Holdings Inc.
Healthcare
|
Held | 13,100 | $1,124,111 | 0.69% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Reduced | 47,531 | $889,305 | 0.55% | |
| GERN |
Geron Corp
Healthcare
|
NEW | 624,046 | $798,778 | 0.49% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
NEW | 10,110 | $709,722 | 0.44% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
NEW | 276,165 | $604,801 | 0.37% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.